BRIEF-Teradyne Q4 Adjusted EPS USD 1.8 Vs. IBES Estimate USD 1.35

Reuters
Feb 03
BRIEF-Teradyne Q4 Adjusted EPS USD 1.8 Vs. IBES Estimate USD 1.35

Feb 02 (Reuters) - Teradyne Q4 revenue USD 1,083 million vs. IBES estimate USD 971.1 million.

  • Q4 EPS USD 1.63
  • Q4 net income USD 257.2 million
  • Q4 adjusted net income USD 283 million vs. IBES estimate USD 212.8 million

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10